Evaluation of cRGD and peptide-modified targeted liposomal Doxorubicin for breast cancer treatment

碩士 === 臺北醫學大學 === 生醫材料暨工程研究所 === 100

Bibliographic Details
Main Authors:	Yun-An Chen, 陳韻安
Other Authors:	Der-Zen Liu
Format:	Others
Language:	zh-TW
Published:	2012
Online Access:	http://ndltd.ncl.edu.tw/handle/63306108223576911835

id	ndltd-TW-100TMC05723006
record_format	oai_dc
spelling	ndltd-TW-100TMC057230062015-10-13T22:07:38Z http://ndltd.ncl.edu.tw/handle/63306108223576911835 Evaluation of cRGD and peptide-modified targeted liposomal Doxorubicin for breast cancer treatment 利用cRGD與短胜肽修飾之標靶微脂粒藥物對於乳癌之治療與評估 Yun-An Chen 陳韻安碩士臺北醫學大學生醫材料暨工程研究所 100 Der-Zen Liu 劉得任 2012 學位論文 ; thesis 96 zh-TW
collection	NDLTD
language	zh-TW
format	Others
sources	NDLTD
description	碩士 === 臺北醫學大學 === 生醫材料暨工程研究所 === 100
author2	Der-Zen Liu
author_facet	Der-Zen Liu Yun-An Chen 陳韻安
author	Yun-An Chen 陳韻安
spellingShingle	Yun-An Chen 陳韻安 Evaluation of cRGD and peptide-modified targeted liposomal Doxorubicin for breast cancer treatment
author_sort	Yun-An Chen
title	Evaluation of cRGD and peptide-modified targeted liposomal Doxorubicin for breast cancer treatment
title_short	Evaluation of cRGD and peptide-modified targeted liposomal Doxorubicin for breast cancer treatment
title_full	Evaluation of cRGD and peptide-modified targeted liposomal Doxorubicin for breast cancer treatment
title_fullStr	Evaluation of cRGD and peptide-modified targeted liposomal Doxorubicin for breast cancer treatment
title_full_unstemmed	Evaluation of cRGD and peptide-modified targeted liposomal Doxorubicin for breast cancer treatment
title_sort	evaluation of crgd and peptide-modified targeted liposomal doxorubicin for breast cancer treatment
publishDate	2012
url	http://ndltd.ncl.edu.tw/handle/63306108223576911835
work_keys_str_mv	AT yunanchen evaluationofcrgdandpeptidemodifiedtargetedliposomaldoxorubicinforbreastcancertreatment AT chényùnān evaluationofcrgdandpeptidemodifiedtargetedliposomaldoxorubicinforbreastcancertreatment AT yunanchen lìyòngcrgdyǔduǎnshèngtàixiūshìzhībiāobǎwēizhīlìyàowùduìyúrǔáizhīzhìliáoyǔpínggū AT chényùnān lìyòngcrgdyǔduǎnshèngtàixiūshìzhībiāobǎwēizhīlìyàowùduìyúrǔáizhīzhìliáoyǔpínggū
_version_	1718073382980812800

Evaluation of cRGD and peptide-modified targeted liposomal Doxorubicin for breast cancer treatment

Similar Items